Market Data

BRANFORD, Conn., March 7, 2012 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. ("CASMED") (Nasdaq:CASM) a leader in medical devices for non-invasive patient monitoring, today announced that Thomas Patton, President and Chief Executive Officer, will present at the 24th Annual ROTH Conference on Tuesday, March 13, 2012 at 8:00 a.m. Pacific time. The conference is being held at The Ritz Carlton in Dana Point, Calif. from March 12 to March 14.

A live webcast of the presentation will be available on the Company's website at www.casmed.com or at http://wsw.com/webcast/roth26/casm/. The archived replay will be available following the live presentation for 90 days.

About CASMED® - Monitoring What's Vital

CASMED is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximeter is the only cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for all patients, regardless of age or weight.   Direct monitoring of tissue oxygenation provides a unique and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues thereby allowing them to intervene appropriately in the care of their patients. In addition to FORE-SIGHT Oximeters and accessories, the Company provides a line of bedside patient vital signs monitoring products, proprietary non-invasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies, and service. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.

For further information regarding CASMED, visit the Company's website at www.casmed.com.

CONTACT: Company Contacts
         CAS Medical Systems, Inc.
         Jeffery Baird
         Chief Financial Officer
         203-315-6303
         ir@casmed.com
         
         Investors
         LHA
         Kim Sutton Golodetz (kgolodetz@lhai.com)
         (212) 838-3777
         or
         Bruce Voss (bvoss@lhai.com)
         (310) 691-7100
         @LHA_IR_PR